Skip to main content
. 2018 Apr 22;319(17):1781–1789. doi: 10.1001/jama.2018.3627

Table 2. Baseline Urinary Isolates and Their Susceptibilities by Treatment Allocation.

No. (%)
Nitrofurantoin
(n = 255)
Fosfomycin
(n = 258)
Baseline cultures obtained 243 (95) 244 (95)
Positive culturesa 194 (80) 183 (75)
Escherichia colib 111 (57) 119 (65)
Nitrofurantoin resistant 2 (1) 4 (3)
Fosfomycin resistant 0 (0) 1 (1)
Co-trimoxazole resistant 26 (23) 25 (21)
Fluoroquinolone resistant 13 (12) 14 (12)
Extended-spectrum beta-lactamase 7 (6) 2 (1)
Klebsiella sppb 20 (10) 7 (4)
Nitrofurantoin resistant 3 (15) 0 (0)
Fosfomycin resistant 2 (10) 0 (0)
Co-trimoxazole resistant 4 (20) 2 (29)
Fluoroquinolone resistant 1 (5) 1 (14)
Extended-spectrum beta-lactamase 2 (10) 1 (14)
Proteus sppb 7 (4) 10 (5)
Nitrofurantoin resistant 6 (86) 9 (90)
Fosfomycin resistant 0 (0) 2 (20)
Co-trimoxazole resistant 3 (42) 2 (20)
Fluoroquinolone resistant 2 (29) 0 (0)
Extended-spectrum beta-lactamase 0 (0) 0 (0)
Enterococcus sppb 13 (7) 14 (7)
Group B Streptococcusb 7 (4) 6 (3)
Enterobacter sppb 5 (3) 4 (2)
Mixed florab 51 (26) 40 (21)
Otherb,c 10 (5) 7 (4)
a

Positive culture was defined as the growth of 103 colony-forming units/mL or more of at least 1 uropathogen; laboratory reporting of culture growth is described in detail in the eAppendix in Supplement 3. All patients were symptomatic at baseline, thus those with a positive culture had confirmed urinary tract infection. Patients with mixed flora at baseline could not be analyzed for microbiologic outcomes.

b

Some cultures had polymicrobial growth.

c

Citrobacter koseri, Morganella spp, Staphylococcus aureus, Staphylococcus saprophyticus, and Streptococcus anginosus.